Clinic
Urgent Care at Lake Lucille INC
Urgent Care at Lake Lucille INC was paid $1.44M by Medicaid between Jan 2018 and Dec 2024, across 25 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoURGENT CARE AT LAKE LUCILLE INC
WASILLA, AK 99654
WASILLA, AK 99654
33aNPI1275587768assigned 05/20/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$1.44M
24GClaims15,437
24DCodes billed25
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Alaska
Rank by total paid#7 of 15
Median peer was paid$1.10M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,311 | $282K | |
| 2019 | 2,699 | $296K | |
| 2020 | 1,584 | $167K | |
| 2021 | 3,162 | $207K | |
| 2022 | 2,234 | $188K | |
| 2023 | 1,414 | $115K | |
| 2024incomplete | 2,033 | $181K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 5,005 | 4,310 | $643K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24% | 2,716 | 2,503 | $346K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 3,048 | 2,583 | $289K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 477 | 422 | $23K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.6% | 263 | 247 | $23K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 1.4% | 691 | 620 | $20K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 1.1% | 32 | 31 | $16K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 86 | 77 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 475 | 446 | $13K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 440 | 361 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 744 | 320 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 163 | 145 | $7K |
13 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 472 | $6K |
| 0002A | <1% | 185 | $5K | |
| 0001A | <1% | 153 | $4K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 44 | $1K |
| 81025 | <1% | 26 | $223.86 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 75 | $39.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 39 | $21.95 |
| 81003 | <1% | 44 | $3.08 | |
| 99072 | 0% | 102 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 82 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 20 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 15 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVAROSI, ELLEN (FINANCIAL OFFICER)